Samer Al Hadidi: Are We Reaching the Limits of BCMA-Targeted Innovation?
Samer Al Hadidi/LinkedIn

Samer Al Hadidi: Are We Reaching the Limits of BCMA-Targeted Innovation?

Samer Al Hadidi, Associate Professor at the Harold C. Simmons Comprehensive Cancer Center/UT Southwestern Medical Center shared on LinkedIn:

“I will be speaking at the 2026 AAADV (Accelerating Anticancer Agent Development and Validation )workshop , session.

Me Too or Not Me Too with a title of the talk: BCMA Saturation: Redundancy or Real Choice?

Location: UT Southwestern Simmons Cancer Center
Date: November 5–6, 2026. North Bethesda

Open for in person and virtual options.”

Other articles from Samer Al Hadidi on OncoDaily.